Publication
Navigating international trade and tariffs
Impacts of evolving trade regulations and compliance risks
Mitigating tariff risks for healthcare in US and Canada
Law 360
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
Recent publications
Publication
Low carbon projects: Global hydrogen and CCS market insights
Low carbon projects, especially those involving hydrogen and carbon capture and storage (CCS), play a crucial role in the journey towards global decarbonization.
Publication
Understanding hydrogen in Indonesia
As a general remark, Indonesia has not, at the date of preparing this summary, issued any regulation on hydrogen production, distribution and trade. It is expected that the upcoming New and Renewable Energy Law will provide a legal framework for the exploitation and utilisation of various new energy sources, including hydrogen.
Subscribe and stay up to date with the latest legal news, information and events . . .